1. Home
  2. TECH

as of 02-17-2026 3:45pm EST

$58.52
$1.41
-2.35%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Founded: 1976 Country:
N/A
Employees: N/A City: MINNEAPOLIS
Market Cap: 10.2B IPO Year: N/A
Target Price: $72.67 AVG Volume (30 days): 2.6M
Analyst Decision: Buy Number of Analysts: 13
Dividend Yield:
0.55%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $46.01 - $72.16 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 2.49% Revenue Growth (next year): 6.40%
P/E Ratio: 112.66 Index:
Free Cash Flow: N/A FCF Growth: -12.30%

AI-Powered TECH Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 67.32%
67.32%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Bio-Techne Corp News

TECH Breaking Stock News: Dive into TECH Ticker-Specific Updates for Smart Investing

All TECH News

Share on Social Networks: